October 4, 2016 / 1:22 PM / a year ago

BUZZ-Aralez Pharmaceuticals Inc: To buy AstraZeneca drug's U.S. rights

** Canadian specialty pharmaceutical's U.S.-listed shares up 12.9 pct at $5.71 premarket, set to open at over 1- month high

** Company to buy U.S. rights of AstraZeneca Plc's old beta-blocker heart drug, Toprol-XL

** "With this deal, (Aralez) should be profitable on an adjusted EBITDA basis in 2017 and we had not expected profitability until 2020," Guggenheim analysts write

** Aralez to pay $175 mln upfront to buy U.S. rights to Toprol-XL tablets and up to $48 mln in milestone and sales-related payments, as well as mid-teen percentage royalties on sales

** Aralez expects deal to immediately add to adjusted EBITDA

** Up to Monday's close, stock lost more than a quarter of its value YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below